ketoconazole has been researched along with isomethyleugenol in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (30.00) | 18.2507 |
2000's | 5 (50.00) | 29.6817 |
2010's | 2 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bonaly, R; Coulon, J; Harmouch, N | 1 |
Jones, BC; Smith, DA; Tyman, CA | 1 |
Linnet, K; Olesen, OV | 1 |
Ekins, S; Mankowski, DC; Margolis, JM; O'Donnell, JP; Obach, RS | 1 |
Greenblatt, DJ; Hesse, LM; Shader, RI; Venkatakrishnan, K; von Moltke, LL | 1 |
Howald, W; Lalovic, B; Phillips, B; Risler, LL; Shen, DD | 1 |
Kunze, KL; Lee, CA; Zhao, P | 1 |
Derks, M; Fowler, S; Kuhlmann, O | 1 |
Kwan, HY; Thormann, W | 1 |
Chen, Y; Guo, X; Li, Q; Peng, Y; Yang, X; Zhao, G; Zheng, J | 1 |
1 trial(s) available for ketoconazole and isomethyleugenol
Article | Year |
---|---|
A single-center, open-label, one-sequence study of dalcetrapib coadministered with ketoconazole, and an in vitro study of the S-methyl metabolite of dalcetrapib.
Topics: Administration, Oral; Adolescent; Adult; Aged; Amides; Anticholesteremic Agents; Antifungal Agents; Biotransformation; Cohort Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Administration Schedule; Drug Interactions; Esters; Humans; In Vitro Techniques; Ketoconazole; Male; Methylation; Microsomes, Liver; Middle Aged; Recombinant Proteins; Sulfhydryl Compounds; Young Adult | 2009 |
9 other study(ies) available for ketoconazole and isomethyleugenol
Article | Year |
---|---|
Identification of 24-methylene-24,25-dihydrolanosterol as a precursor of ergosterol in the yeasts Schizosaccharomyces pombe and Schizosaccharomyces octosporus.
Topics: Binding Sites; Cell Membrane; Ergosterol; Ketoconazole; Lanosterol; Methylation; Schizosaccharomyces; Species Specificity; Sterols | 1995 |
Identification of the cytochrome P450 isoforms involved in the O-demethylation of 4-nitroanisole in human liver microsomes.
Topics: Adult; Aged; Anisoles; Anti-Infective Agents; Anticoagulants; Antifungal Agents; Antimalarials; Binding, Competitive; Coumarins; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Female; Humans; Isoenzymes; Ketoconazole; Kinetics; Male; Methylation; Microsomes, Liver; Middle Aged; Quinidine; Substrate Specificity; Sulfaphenazole; Theophylline | 1997 |
Studies on the stereoselective metabolism of citalopram by human liver microsomes and cDNA-expressed cytochrome P450 enzymes.
Topics: Citalopram; Cytochrome P-450 Enzyme System; DNA, Complementary; Fluvoxamine; Gene Expression; Humans; Ketoconazole; Kinetics; Methylation; Microsomes, Liver; Oxidation-Reduction; Quinidine; Recombinant Proteins; Stereoisomerism | 1999 |
(R)-, (S)-, and racemic fluoxetine N-demethylation by human cytochrome P450 enzymes.
Topics: Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Fluoxetine; Humans; Isoenzymes; Ketoconazole; Kinetics; Methylation; Microsomes, Liver; Quinidine; Recombinant Proteins; Selective Serotonin Reuptake Inhibitors; Stereoisomerism; Sulfaphenazole | 2000 |
CYP3A4 is the major CYP isoform mediating the in vitro hydroxylation and demethylation of flunitrazepam.
Topics: Anti-Anxiety Agents; Benzoflavones; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Flunitrazepam; Humans; Hydroxylation; Isoenzymes; Ketoconazole; Kinetics; Methylation; Microsomes, Liver; Mixed Function Oxygenases; Omeprazole; Quinidine; Ritonavir; Sulfaphenazole; Transfection | 2001 |
Quantitative contribution of CYP2D6 and CYP3A to oxycodone metabolism in human liver and intestinal microsomes.
Topics: Aryl Hydrocarbon Hydroxylases; Biotransformation; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; DNA, Complementary; Humans; Intestinal Mucosa; Intestines; Ketoconazole; Kinetics; Metabolic Clearance Rate; Methylation; Microsomes; Microsomes, Liver; Molecular Structure; Morphinans; Oxidoreductases, N-Demethylating; Oxycodone; Oxymorphone; Protein Binding; Quinidine | 2004 |
Sequential metabolism is responsible for diltiazem-induced time-dependent loss of CYP3A.
Topics: Antifungal Agents; Calcium Channel Blockers; Cells, Cultured; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Diltiazem; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hepatocytes; Humans; Ketoconazole; Kinetics; Methylation; Microsomes, Liver; Molecular Structure; Time Factors | 2007 |
Enantioselective capillary electrophoresis for the assessment of CYP3A4-mediated ketamine demethylation and inhibition in vitro.
Topics: beta-Cyclodextrins; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Electrophoresis, Capillary; gamma-Cyclodextrins; Humans; Ketamine; Ketoconazole; Kinetics; Methylation; Nonlinear Dynamics; Recombinant Proteins; Stereoisomerism | 2011 |
Studies on hepatotoxicity and toxicokinetics of colchicine.
Topics: Animals; Colchicine; Cytochrome P-450 CYP3A; Ketoconazole; Liver; Male; Methylation; Mice | 2019 |